Exagen Inc (NAS:XGN)
$ 2.75 -0.04 (-1.43%) Market Cap: 47.81 Mil Enterprise Value: 47.91 Mil PE Ratio: 0 PB Ratio: 2.72 GF Score: 70/100

Q2 2020 Exagen Inc Earnings Call Transcript

Jul 28, 2020 / 12:00PM GMT
Release Date Price: $11.73 (+6.64%)
Operator

Greetings, and welcome to the Exagen, Inc. Second Quarter 2020 Earnings Call. (Operator Instructions). As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Mr. Mark Hazeltine, Senior Vice President of Finance and Corporate Development for Exagen, Inc. Thank you. You may begin.

Mark Hazeltine
Exagen Inc. - SVP of Finance & Corporate Development

Good morning, and thank you for joining us today. Early this morning, Exagen, Inc. released financial results for the quarter ended June 30, 2020. The release is currently available on the company's website at www.exagen.com. Ron Rocca, President and Chief Executive Officer; and Kamal Adawi, Chief Financial Officer, will host this afternoon's call.

Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot